Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
MediumReport
Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
MediumReport
Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence [Yahoo! Finance]
HighReport
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence [Yahoo! Finance]
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: